Israel - English - Ministry of Health

novartis israel ltd - epirubicin hydrochloride - concentrate for solution for infusion - epirubicin hydrochloride 2 mg/ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of farmorubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after stransurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - epirubicin hydrochloride - solution for injection - 2mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - epirubicin hydrochloride - solution for infusion - 2mg/1ml

Israel - English - Ministry of Health

mbi pharma ltd., israel - epirubicin hydrochloride - solution for injection - epirubicin hydrochloride 50 mg / 25 ml - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma (high doses), ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

actavis italy s.p.a. - epirubicin (epirubicin hydrochloride) - powder lyophilized for solution for infusion - 50mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

actavis italy s.p.a. - epirubicin (epirubicin hydrochloride) - powder lyophilized for solution for infusion - 10mg

Israel - English - Ministry of Health

salomon,levin & elstein ltd - epirubicin hydrochloride 2 mg / 1 ml - solution for injection / infusion - epirubicin - for the treatment of wide spectrum of neoplastic diseases, including:- breast carcinoma- lung carcinoma - high doses- ovarian carcinoma- gastric carcinomas- soft tissue sarcoma- i.v. administration for the treatment of advanced bladder carcinoma- intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection.

Israel - English - Ministry of Health

inovamed ltd - epirubicin hydrochloride - solution for injection - epirubicin hydrochloride 2 mg / 1 ml - epirubicin - epirubicin - for the treatment of wide spectrum of neoplastic diseases including breast carcinoma, lung carcinoma high doses, ovarian carcinoma, gastric carcinomas, soft tissue sarcoma. intravesical administration of epirubicin has been found to be beneficial in the treatment of superficial bladder carcinomas and in the prophylaxis of recurrences after transurethral resection. i.v. administration for the treatment of advanced bladder carcinoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

seacross pharmaceuticals limited - epirubicin hydrochloride - solution for injection - 2 mg/ml - epirubicin